Clinical trials: Radiodermatitis
Radiation-induced Dermatitis
Study of ST266 Versus Saline in Treating Skin Irritation From Radiation
The objective of this study is to evaluate the safety and efficacy of ST266 in treating radiation burns of the skin in patients undergoing treatments for breast cancer and to compare ST266 treated burns with those treated with…
- Trial name
- NCT01714973
- Testing
- ST266
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Noveome Biotherapeutics, formerly Stemnion
Radiodermatitis, Radiation Toxicity
Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.
The aim is to quantify the efficiency of the Safetac product Mepitel® Film on the prevention of radiodermatitis for cancer patients treated with external beam radiation therapy near the inguinal fold(s).
- Conditions
- Radiodermatitis, Radiation Toxicity, Radiotherapy Side Effect
- Trial name
- NCT04617730
- Testing
- Mepitel® film, Flamigel®
- Volunteers
- 35 people
- Sponsor
- Jules Bordet Institute
Breast Cancer, Radio Dermatitis
Autologous Fat Infiltration Versus General Measures as Treatment in Radiodermatitis Induced for Radiotherapy in Breast Cancer Patients
Radiodermatitis is a major problem in oncologic patients, fat grafts previously used for cosmetic procedures have been shown to have regenerative power due to their stem cell content.
- Conditions
- Breast Cancer, Radio Dermatitis, Radiotherapy
- Trial name
- NCT07023796
- Testing
- Autologous fat filtration
- Where
- Mexico
- Volunteers
- 22 people
- Sponsor
- Instituto Mexicano del Seguro Social
Head and Neck Carcinoma, Radiation-Induced Dermatitis
Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy
This randomized phase 3 trial studies how well modified Dakin's solution works in reducing radiation-induced dermatitis, a common skin reaction to radiation therapy, in patients with head and neck cancer undergoing radiation…
- Trial name
- NCT02369835
- Testing
- Dakin's solution
- Where
- 2 sites in United States
- Volunteers
- 132 people
- Sponsor
- Stanford University
Dermatitis, Radiation Induced
Efficacy of Pulsed Electromagnetic Field Therapy on Acute Radiodermatitis in Breast Cancer Patients
This study aims to evaluate the impact of PEMF on acute radiodermatitis in breast cancer patient and post mastectomy patients.
- Trial name
- NCT06003764
- Testing
- Pulsed electromagnetic field, traditional skin care
- Where
- Egypt
- Volunteers
- 50 people
- Sponsor
- Ahram Canadian University
Radiation Dermatitis
Clinical Trial of CSMed Wound Dressing for Radiation Dermatitis
Investigate the effects of CSMed® for preventing and managing radiation dermatitis in patients with Breast cancer and Head-Neck cancer receiving radiotherapy (≥50 Gy).
- Trial name
- NCT06001463
- Testing
- CSMed Dressing
- Where
- Taiwan
- Volunteers
- 30 people
- Sponsor
- Chung Shan Medical University
Head Cancer, Neck Cancer
Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients
Up to 90% of the radiotherapy patients will develop a certain degree of skin reaction at the treated area, also known as radiodermatitis (RD).
- Trial name
- DERMISHEAD (NCT02738268)
- Testing
- Low-level laser therapy
- Where
- 2 sites in Belgium
- Volunteers
- 46 people
- Sponsor
- Hasselt University
Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM)
Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients
1. To evaluate the preventive and therapeutic effects of Qibei Jiedu Formula on acute radiation dermatitis in breast cancer patients, including the incidence of grade 2 or higher radiation dermatitis, wound healing time, and…
- Conditions
- Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer
- Trial name
- NCT07380230
- Testing
- Standard Basic Treatment Combined with Qibei Jiedu Formula, Standard Basic Treatment Combined with Qibei Jiedu Formula simulator
- Where
- China
- Volunteers
- 60 people
- Sponsor
- LI FENG
Rectal Cancer, Radiotherapy, Anal Pain
Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin
Background: According to GLOBOCAN 2022 statistics, colorectal cancer has become the third most common cancer disease worldwide, and also the second leading cause of death.
- Conditions
- Rectal Cancer, Radiotherapy, Anal Pain, Acute Radiation Dermatitis, Anal Canal
- Trial name
- NCT06837831
- Testing
- Control group, Experimental group
- Where
- China
- Volunteers
- 274 people
- Sponsor
- Qianfoshan Hospital
Radiation Dermatitis
M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis
The purpose of this research study is to test the ability of a mobile device application (MyCap) to collect patient information about their radiation skin rash in patients with head and neck cancer being treated with radiation…
- Trial name
- NCT06441266
- Testing
- KeraStat cream, M-PART Assessments via MyCap, Clinical Assessments
- Where
- United States
- Volunteers
- 16 people
- Sponsor
- Wake Forest University Health Sciences
Breast Cancer, Radiodermatitis
Photobiomodulation for Breast Cancer Radiodermatitis
A prospective single blind controlled randomized trial to evaluate the superiority of photobiomodulation (PBM) using LED-therapy in reducing the prevalence of radiodermatitis in breast cancer compared to usual local care.
- Conditions
- Breast Cancer, Radiodermatitis, Radiotherapy Side Effect, Radiation Dermatitis
- Trial name
- NCT04059809
- Testing
- Photobiomodulation
- Where
- Brazil
- Volunteers
- 48 people
- Sponsor
- AC Camargo Cancer Center
Radiation Dermatitis
StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis
Current clinical practice for preventing and treating radiation dermatitis across Queensland (QLD) Health Radiation Oncology departments involves the application of aqueous cream daily to the skin of the treatment site…
- Trial name
- NCT05450848
- Testing
- StrataXRT, Sorbolene
- Where
- 2 sites in Australia
- Volunteers
- 105 people
- Sponsor
- Stratpharma AG
Radiation Dermatitis
Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis
The main purpose of this study is to demonstrate the safety and efficacy of KAM1403 GEL in reducing the symptoms of mild to moderate Radiation Dermatitis.
- Trial name
- kam1403 (NCT02051907)
- Testing
- KAM1403 Gel, aloevera gel
- Where
- Israel
- Volunteers
- 60 people
- Sponsor
- Kamedis Ltd.
Acute Radiation Dermatitis
Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis
Acute radiation dermatitis (ARD) is almost universally experienced by patients with cancer during or after radiation therapy. This condition potentially leads to detrimental clinical outcomes as it adversely affects adherence to…
- Trial name
- NCT05079763
- Testing
- Bacterial cellulose-monolaurin hydrogel
- Where
- Philippines
- Volunteers
- 54 people
- Sponsor
- University of the Philippines
Radiodermatitis, Oncology
Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.
Testing the efficacy of the Jalosome® Soothing gel in 2 or 3 grade radiodermatitis healing in oncological patients. The investigators would like to know also the efficacy of the device on quality of life and pain.
- Conditions
- Radiodermatitis, Oncology, Quality of Life, Pain
- Trial name
- NCT04692389
- Testing
- Jalosome soothing gel
- Where
- Switzerland
- Sponsor
- Welcare Industries SpA
Acute Radiation Dermatitis, Head and Neck Cancer (H&N)
Effectiveness of 0.9% Normal Saline Soaking in Managing Acute Radiation Dermatitis
The goal of this clinical trial is to learn if normal saline soaks can reduce the severity of acute radiation dermatitis in patients with sarcomas or head and neck cancer receiving radiotherapy.
- Conditions
- Acute Radiation Dermatitis, Head and Neck Cancer (H&N), Sarcomas
- Trial name
- NCT07553260
- Testing
- Normal Saline Soaks (0.9% Sodium Chloride)
- Where
- Jordan
- Volunteers
- 150 people
- Sponsor
- King Hussein Cancer Center
Breast Cancer, Radiation Dermatitis
Mepitel Film Breast
Primary Objective To examine the tolerability of Mepitel Film in the prevention of RD patients undergoing whole breast or chest wall RT in the hot and humid weather in Singapore Secondary Objectives To evaluate the incidence of…
- Trial name
- NCT07729423
- Where
- Singapore
- Volunteers
- 60 people
- Sponsor
- National University Hospital, Singapore
Breast Cancer, Radiation Dermatitis
MediHoney for Radiation Dermatitis
The aim of this study is to compare the effects of Medihoney and Hydrophor on radiation dermatitis reactions in a group of women undergoing radiation therapy for breast cancer.
- Trial name
- NCT02234479
- Testing
- Hydrophor (Group A), MediHoney (Group B)
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- University of Maryland, Baltimore
Breast Carcinoma, Head and Neck Carcinoma
StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients
This clinical trial studies the effect of StrataXRT in preventing and treating radiation dermatitis in breast cancer or head and neck cancer patients. Radiotherapy is often associated with multiple side effects.
- Conditions
- Breast Carcinoma, Head and Neck Carcinoma, Radiation-Induced Dermatitis
- Trial name
- NCT05073172
- Testing
- Calendula Ointment, Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment, Polyethylene Glycol Hydrogel
- Where
- United States
- Sponsor
- OHSU Knight Cancer Institute
Radiodermatitis
Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients
This trial is designed as a multicenter, double-blinded, randomized, placebo controlled study to assess the safety and efficacy of JBM-TC4 for the prevention and treatment of acute radiation-induced dermatitis in breast cancer…
- Trial name
- NCT02289365
- Testing
- 2000 mg of JBM-TC4 per day, 3000 mg of JBM-TC4 per day, 3000 mg of PEG-400 per day
- Where
- 3 sites in Taiwan
- Volunteers
- 120 people
- Sponsor
- Joben Bio-Medical Co., Ltd.